Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lee Foundation
Hefei, Anhui, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Multiple approved products including Socazolimab Injection (oncology), Natulan® (Procarbazine Hydrochloride Capsules, oncology), INOmax® (rare diseases), and generics like Nadroparin Calcium Injection; over 40 products in pipeline from early to late-stage.
- Therapeutic areas
- OtherWomen's HealthCardiovascularDermatologyInfectious DiseasesRare DiseasesOncologyOphthalmology
- Modalities
- Small moleculeRecombinant proteinBiologic
- Industry
- Biotech
02
Partnerships
Shaohe Biotechnology Co., Ltd.GP-Pharm P.A.>20 international companies from US, Europe, Japan, South Korea
Beyond the preview
Go deeper on Lee Foundation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lee Foundation.